Health fraud and the resurgence of quackery in the United States: A warning to the European Union

Pharmaceuticals Policy and Law

Volumn 11, Issue 3, 2009, Pages 113-152

  Steven Pray, W ^a  

^a SOUTHWESTERN OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85013588954     PISSN: 13892827     EISSN: 2210495X     Source Type: Journal    
DOI: 10.3233/PPL-2009-0216     Document Type: Article

References (196)

1. V.S. Cowart, Health fraud’s toll: lost hopes, misspent billions, JAMA 259(22) (1988), 3229-3330.
2. J.E. Dodes and M.J. Schissel, Quacks among us, NY State Dent J 61(7) (1995), 16-17.
3. J.S. Goodwin and M.R. Tangum, Battling quackery, Arch Intern Med 158(20) (1998), 2187-2191.
4. M.L. Brigden, Unorthodox therapy and your cancer patient, Postgrad Med 81(1) (1987), 271-272;275-277;280.
5. S. Barrett, Fighting quackery-a quick-reference guide, Postgrad Med 81(7) (1987), 13;16;21.
6. V. Herbert, Unproven (questionable) dietary and nutritional methods in cancer prevention and treatment, Cancer 58(8)(Supplement) (1986), 1930-1941.
7. B.P. Squires, Why quackery thrives, CMAJ 138(11) (1988), 999-1000.
8. M. Bigby, Snake oil for the 21st century, Arch Dermatol 134(12) (1998), 1512-1514.
9. D.M. Brunette, Alternative therapies: abuses of scientific method and challenges to dental research, J Prosthet Dent 80(5) (1998), 605-614.
10. T.T. Perls, Anti-aging quackery: Human growth hormone and tricks of the trade - more dangerous than ever, J Gerontol A Biol Sci Med Sci 59(7) (2004), 682-691.
11. R.B. Stevenson, Quackery, fraud, and denturists, J Am Coll Dent 70(3) (2003), 34-37.
12. D.W. Chambers, Quackery and fraud: understanding the ethical issues and responding, J Am Coll Dent 70(3) (2003), 9-17.
13. Anon, The ethics of quackery and fraud in dentistry: A position paper, J Am Coll Dent 70(3) (2003), 6-8.
14. K.E. Follmar, Taking a stand against fraud and quackery in dentistry, J Am Coll Dent 70(3) (2003), 4-5.
15. W.T. Jarvis, Quackery: A national scandal, Clin Chem 38(8B Pt 2) (1992), 1574-1586.
16. S.H. Short, Health quackery: our role as professionals, J Am Diet Assoc 94(6) (1994), 607-611.
17. Ascher E. Nostrums, quackery, and ethics in vascular surgery: How to remain true to the path of Hippocrates and still feed our families, J Vasc Surg 40(2) (2004), 389-394.
18. M.J. Mehlman, Quackery, Am J Law Med 31(2-3) (2005), 349-363.
19. M.J. Schissel and J.E. Dodes, Dentistry and alternative therapy, NY State Dent J 63(3) (1997), 32-37.
20. D.E. Hanson, Different viewpoints on alternative medicine (Letter), Am Fam Physician 55(6) (1997), 2080;2082.
21. W.I. Wardwell, Alternative medicine in the United States, Soc Sci Med 38(8) (1994), 1061-1068.
22. M. Baum, Quack cancer cures or scientific remedies, JR Soc Med 89(10) (1996), 543-547.
23. R.L. Koretz, Is alternative medicine alternative science? J Lab Clin Med 139(6) (2002), 329-333.
24. E. Ernst, M.H. Pittler and C. Stevinson, Complementary/alternative medicine in dermatology: evidence-assessed efficacy of two diseases and two treatments, Am J Clin Dermatol 3(5) (2002), 341-348.
25. F.A. Sonnenberg, Health information on the Internet, Arch Intern Med 157(2) (1997), 151-152.
26. B. Keoun, Cancer patients find quackery on the web, J Natl Cancer Inst 88(18) (1996), 1263-1265.
27. K. Schmidt and E. Ernst, Assessing websites on complementary and alternative medicine for cancer, Ann Oncol 15(5) (2004), 733-742.
28. K.L. Milstead, Enforcement of antiquackery laws, J Am Pharm Assoc NS3 (1963), 458-460.
29. Anon, Quackery-the billion dollar miracle business (pamphlet), Rockville, MD; Food and Drug Administration, 1990.
30. M. Angell and J.P. Kassirer, Alternative medicine-the risks of untested and unregulated remedies, NEJM 339(12) (1998), 839-841.
31. S.Wilkinson and G.W. Chodak, Critical review of complementary therapies for prostate cancer, J Clin Oncol 21(11) (2003), 2199-2210.
32. S.C. Halbert, Diet and nutrition in primary care, Prim Care 24(4) (1997), 825-843.
33. D.J. Tessier and D.S. Bash, A surgeon’s guide to herbal supplements, J Surg Res 114(1) (2003), 30-36.
34. J.S. Levin, T.A. Glass, L.H. Kushi, J.R. Schuck, L. Steele and W.B. Jonas, Quantitative methods in research on complementary and alternative medicine, Med Care 35(11) (1997), 1079-1094.
35. J.J. Brokaw, G. Tunnicliff, B.U. Raess and D.W. Saxon, The teaching of complementary and alternative medicine in US medical schools: a survey of course directors, Acad Med 77(9) (2002), 876-881.
36. D.W. Saxon, G. Tunnicliff, J.J. Brokaw and B.U. Raess, Status of complementary and alternative medicine in the osteopathic medical school curriculum, J Am Osteopath Assoc 104(3) (2004), 121-126.
37. G. O’Connor, Confidence trick, Med J Aust 147(9) (1987), 456;458-459.
38. L.H. Altshuler, Alternative medicines: what is the physician’s role? J Okla State Med Assoc 92(5) (1999), 219-226.
39. K.L. Soeken, Selected CAM therapies for arthritis-related pain: the evidence from systematic reviews, Clin J Pain 20(1) (2004), 13-18.
40. J.N. Dillard and S. Knapp, Complementary and alternative pain therapy in the emergency department, Emerg Med Clin North Am 23(2) (2005), 529-549.
41. O. Caspi, M. Koithan and M.W. Criddle, Alternative medicine or "alternative" patients: a qualitative study of patient-oriented decision-making processes with respect to complementary and alternative medicine, Med Decis Making 24(1) (2004), 64-79.
42. W.S. Pray, Early federal regulation of foods and drugs, in: A History of Nonprescription Product Regulation, W.S. Pray, ed., The Haworth Press, Inc. New York, 2003, pp. 5-8.
43. W.S. Pray, The predatory patent medicines, in: A History of Nonprescription Product Regulation, W.S. Pray, ed., The Haworth Press, Inc. New York, 2003, pp. 9-31.
44. A.P. Ferry, "Professor"William C.Wilson and his Actina Electric Pocket Battery for curing ocular disease, Ophthalmology 105(2) (1998), 238-248.
45. W.S. Pray, The 1906 Pure Food and Drugs Act, in: A History of Nonprescription Product Regulation, W.S. Pray, ed., The Haworth Press, Inc. New York, 2003, pp. 33-75.
46. W.S. Pray, The fight against baby killers: The Harrison Narcotic Act of 1914, in: A History of Nonprescription Product Regulation, W.S. Pray, ed., The Haworth Press, Inc. New York, 2003, pp. 77-90.
47. W.S. Pray, The 1938 Federal Food, Drug, and Cosmetic Act: safety required, in: A History of Nonprescription Product Regulation, W.S. Pray, ed., The Haworth Press, Inc. New York, 2003, pp. 91-129.
48. W.S. Pray, The 1962 Kefauver-Harris Amendments: proof of effectiveness, in: A History of Nonprescription Product Regulation, W.S. Pray, The Haworth Press, Inc. NewYork, 2003, pp. 147-172.
49. W.S. Pray, The FDA OTC Review and Rx-to-OTC switching, in: A History of Nonprescription Product Regulation, W.S. Pray, The Haworth Press, Inc. New York, 2003, pp. 173-187.
50. W.S. Pray, Homeopathy, in: A History of Nonprescription Product Regulation, W.S. Pray, ed., The Haworth Press, Inc. New York, 2003, pp. 189-204.
51. W.S. Pray, A history of dietary supplement regulation, in: A History of Nonprescription Product Regulation, W.S. Pray, ed., The Haworth Press, Inc. New York, 2003, pp. 205-238.
52. A.J. Iannarone, Scientific basis for health claims for dietary supplements, Food Drug Law J 47(4) (1992), 665-676.
53. B.J. Tesch, Herbs commonly used by women: an evidence-based review, Am J Obstet Gynecol 188(5)(Supplement) (2003), S44-S45.
54. H.L. Thacker and D.L. Booher, Management of perimenopause: focus on alternative therapies, Cleve Clin J Med 66(4) (1999), 213-218.
55. N.R. Slifman, W.R. Obermeyer, S.M. Musser et al., Contamination of botanical dietary supplements by Digitalis lanata, NEJM 339(12) (1998), 806-811.
56. L.C. Winslow and D.J. Kroll, Herbs as medicines, Arch Intern Med 158(20) (1998), 2192-2199.
57. J.S. Lazar and B.B. O’Connnor, Talking with patients about their use of alternative therapies, Prim Care 24(4) (1997), 699-714.
58. J.A. Astin, A. Marie, K.R. Pelletier, E. Hansen and W.L. Haskell, A review of the incorporation of complementary and alternative medicine by mainstream physicians, Arch Intern Med 158(21) (1998), 2303-2310.
59. S.M. Rhee, V.K. Garg and C.O. Hershey, Use of complementary and alternative medicines by ambulatory patients, Arch Intern Med 164(9) (2004), 1004-1009.
60. S.C. Schimpff, Complementary medicine, Curr Opin Oncol 9(4) (1997), 327-331.
61. D. Spiegel, P. Stroud and A. Fyfe, Complementary medicine, West J Med 168(4) (1998), 241-247.
62. P.B. Fontanarosa and G.D. Lundberg, Alternative medicine meets science, JAMA 280(18) (1998), 1618-1619.
63. M. Frenkel, E. Ben-Arye, C.D. Baldwin and V. Sierpina, Approach to communicating with patients about the use of nutritional supplements in cancer care, South Med J 98(3) (2005), 289-294.
64. J. Chatwin and P. Tovey, Complementary and alternative medicine (CAM), cancer and group-based action: a critical review of the literature, Eur J Cancer Care 13(3) (2004), 210-218.
65. A.W. Markham and J.M. Wilkinson, Complementary and alternative medicines (CAM) in the management of asthma: an examination of the evidence, J Asthma 41(2) (2004), 131-139.
66. F.G. Miller, E.J. Emanuel, D.L. Rosenstein and S.E. Straus, Ethical issues concerning research in complementary and alternative medicine, JAMA 291(5) (2004), 599-604.
67. E. Ernst, M.H. Cohen and J. Stone, Ethical problems arising in evidence based complementary and alternative medicine, J Med Ethics 30(2) (2004), 156-159.
68. M. South and A. Lim, Use of complementary and alternative medicine in children: too important to ignore, J Paediatr Child Health 39(8) (2003), 573-574.
69. J.H. Young, The development of the Office of Alternative Medicine in the National Institutes of Health, Bull Hist Med 72 (1998), 279-298.
70. Anon, The NIH Almanac-Organization, National Center for Complementary and Alternative Medicine. Available at: www.nih.gov/about/almanac/organization/NCCAM.htm. Accessed January 5. 2006.
71. Anon, About the National Center for Complementary and Alternative Medicine, The National Center for Complementary and Alternative Medicine. Available at: http://nccam.nih.gov/about/aboutnccam/index.htm. Accessed January 5, 2006.
72. T.N. Gorski, Current issues in protecting the public from health fraud: "Dietary supplements" as a public health problem.Testimony before theUS Senate Special Committee on Aging, 2001, Quackwatch. Available at: http://quackwatch.org/01QuackeryRelatedTopics/Hearing/gorski.html. Accessed January 5, 2006.
73. K.C. Atwood, IV, The ongoing problem with the National Center for Complementary and Alternative Medicine, Committee for the Scientific Investigation of Claims of the Paranormal. Available at: www.csicop.org/si/2003-09/alternative-medicine.html. Accessed January 5, 2006.
74. W.I. Sampson, Why the National Center for Complementary and Alternative Medicine should be defunded, Quackwatch. Available at: www.quackwatch.org/01QuackeryRelatedTopics/nccam.html. Accessed January 5, 2006.
75. R.A. Buerki and L.D. Vottero, Ethical Responsibility in Pharmacy Practice, Madison, WI: American Institute of the History of Pharmacy, 146-162.
76. G. Griffenhagen, Patent medicines to nonprescription drugs, in: 150 Years of Caring, G. Griffenhagen, ed., American Pharmaceutical Association. Washington DC, 2002, pp. 154-157.
77. Anon, Code of ethics for pharmacists, American Pharmacists Association. Available at: www.aphanet.org/AM/Template.cfm?Section=Home&CONTENTID=2654&TEMPLATE=/CM/HTMLDisplay.cfm. Accessed January 5, 2006.
78. Anon, Improving medication use. Advancing patient care, American Pharmacists Association. Available at: www.aphanet.org/AM/Template.cfm?Section=About APhA&CONTENTID=2410& TEMPLATE=/CM/HTMLDisplay.cfm. Accessed January 5, 2006.
79. E.G. Feldman, Harmless, but ineffective, remedies (Editorial), J Pharm Sci 64 (1975), 1584I.
80. J. Moore, R.D. Cobb, R. Gieser et al., Report of the Policy Committee on Public Affairs, Am Pharm NS26(1) (1986), 68-72.
81. M.V. Nelson, Promotion and selling of unnecessary food supplements: Quackery or ethical pharmacy practice? Am Pharm NS28(10) (1988), 34-36.
82. A.H. Kibbe, Policy and science: Inextricably connected, J Am Pharm Assoc 42(4) (2002), 535-536.
83. W.S. Pray, Nonprescription Product Therapeutics, Lippincott Williams & Wilkins. Baltimore, 1999.
84. A.L. Hume, Complementary and alternative medicine, Am J Pharm Educ 71(3) (2007), 1-2.
85. A.L. Hume and K.M. Strong, Botanical medicines, in: Handbook of Nonprescription Drugs, (14th ed.), R.R. Berardi, ed., American Pharmacists Association.Washington, DC, 2004, pp. 1231-1274.
86. B.M. Hausen, Evaluation of the main contact allergens in oxidized tea tree oil, Dermatitis 15(4) (2004), 213-214.
87. E.L. Simpson, S.V. Law and F.J. Storrs, Prevalence of botanical extract allergy in patients with contact dermatitis, Dermatitis 15(2) (2004), 67-72.
88. G.H. Crawford, J.R. Sciacca and W.D. James, Tea tree oil: Cutaneous effects of the extracted oil of Melaleuca alternifolia, Dermatitis 15(2) (2004), 59-66.
89. N.K. Veien, K. Rosner and G.L. Skovgaard, Is tea tree oil an important contact allergen? Contact Dermatitis 50(6) (2004), 378-379.
90. B. Kütting, R. Brehler and H. Traupe, Allergic contact dermatitis in children: Strategies of prevention and risk management, Eur J Dermatol 14(2) (2004), 80-85.
91. L. Scardamaglia, R. Nixon and J. Fewings, Compound tincture of benzoin: A common contact allergen? Australas J Dermatol 44(3) (2003), 180-184.
92. C.M. Perrett, A.V. Evans and R. Russell-Jones, Tea tree oil dermatitis associated with linear IgA disease, Clin Exp Dermatol 28(2) (2003), 167-170.
93. N.B. Mozelsio, K.E. Harris, K.G. McGrath and L.C. Grammer, Immediate systemic hypersensitivity reaction associated with topical application of Australian tea tree oil, Allergy Asthma Proc 24(1) (2003), 73-75.
94. I.B. Bassett, D.L. Pannowitz and R.S. Barnetson, A comparative study of tea-tree oil versus benzoyl peroxide in the treatment of acne, Med J Aust 153(8) (1990), 455-458.
95. D.S. Buck, D.M. Nidorf and J.G. Addino, Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole, J Fam Pract 38(6) (1994), 601-605.
96. A.L. Hume and K.M. Strong, Botanical medicines, in: Handbook of Nonprescription Drugs, (13th ed.), R.R. Berardi, ed., American Pharmaceutical Association. Washington, DC, 2002, pp. 1065-1100.
97. Anon, Kava-containing dietary supplements may be associated with severe liver injury. Food and Drug Administration. Available at: www.cfsan.fda.gov/-dms/addskava.html. Accessed March 12, 2007.
98. Anon, Hepatic toxicity possibly associated with kava-containing products - United States, Germany, and Switzerland, 1999-2002. Centers for Disease Control. Available at: www.cdc.gov/MMWR/preview/mmwrhtml/mm5147a1.htm. Accessed March 12, 2007.
99. Anon, Kava linked to liver damage. National Center for Complementary and Alternative Medicine. Available at: nccam.nih.gov/health/ alerts/kava/. Accessed March 12, 2007.
100. Anon, Chamomile (Matricaria recutita, Chamaemelum nobile). National Library of Medicine/National Institutes of Health. Available at: www.nlm.nih.gov/medlineplus/druginfo/natural/patient-chamomile.html. Accessed March 12, 2007.
101. Anon, Center for Drug Evaluation and Research Key Officials. Food and Drug Administration. Available at: www.fda.gov/cder/directories/keyoffic.pdf. Accessed March 12, 2007.
102. Anon, Review by CDER. Food and Drug Administration. Available at: www.fda.gov/cder/hand book/index.htm. Accessed March 12, 2007.
103. Anon, Over-the-counter drug products. Available at: www.fda.gov/cder/handbook/index.htm. Accessed March 12, 2007.
104. K. Skau, Pharmacy is a science-based profession, Am J Pharm Educ 71(1) (2007), 11.
105. Anon, Bowel nosodes. Available at: www.askahomeopath.net/bowelnosodes.htm. Accessed March 12, 2007.
106. Anon, Homeopathic urine formula. Available at: www.abchomeopathy.com/forum2.php/47447/. Accessed March 12, 2007.
107. Anon, Yeast Gard Homeopathic Vaginal Suppositories. Available at: www.lakeconsumer.com/product.shtml#head1. Accessed March 12, 2007.
108. S. Barrett, Craniosacral therapy. Available at: www.quackwatch.org/01QuackeryRelatedTopics/cranial.html. Accessed March 12, 2007.
109. D. Foreman, Lifesaving bacteria, Pharm Today 11(5) (2005), 6.
110. Anon, Product showcase, Pharm Today 11(8) (2005), 6.
111. Anon, Hyland’s Complete Flu Care 4 Kids, MyHealthCare21.com. Available at: www.myhealthcare21.com/HY152/Complete-Flu-Care.html. Accessed January 6, 2006.
112. E.W. Guthrie, Lessons learned from early Americans, Pharm Today 11(9) (2005), 6.
113. D. Foreman, The ancient beverage that heals, Pharm Today 11(9) (2005), 12;31.
114. Anon, Zicam (Advertisement), Pharm Today 12(11) (2006), 11.
115. T.H. Alexander and T.M. Davidson, Intranasal zinc and anosmia: The zinc-induced anosmia syndrome, Laryngoscope 116(2) (2006), 217-220.
116. G.A. Eby and W.W. Halcomb, Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: A double-blind, placebo-controlled clinical trial, Altern Ther Health Med 12(1) (2006), 34-38.
117. B.W. Jafek, M.R. Linschoten and B.W. Murrow, Anosmia after intranasal zinc gluconate use, Am J Rhinol 18(3) (2004), 137-141.
118. R.B. Turner, Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds, Clin Infect Dis 33(11) (2001), 1865-1870.
119. R.B. Turner and W.E. Cetnarowski, Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds, Clin Infect Dis 31(5) (2000), 1202-1208.
120. J.L. Jackson, E. Lesho and C. Peterson, Zinc and the common cold: A meta-analysis revisited, J Nutr 130(5S Suppl) (2000), 1512S-1515S.
121. K. McBride, B. Slotnick and F.L. Margolis, Does intranasal application of zinc sulfate produce anosmia in the mouse? An olfactometric and anatomical study, Chem Senses 28(8) (2003), 659-670.
122. E.A. Belongia, R. Berg and K. Liu, A randomized trial of zinc nasal spray for the treatment of upper respiratory illness in adults, Am J Med 111(2) (2001), 103-108.
123. K.A. Hodges, Elephant Pharmacy caters to all, Pharm Today 12(11) (2006), 36-38.
124. Anon, Nutripuncture. Acupuncture Los Angeles Santa Monica. Available at: www. laacupuncturelosangeles.com/html/nutripuncture.html. Accessed March 13, 2007.
125. Anon, Elephant Pharm Berkeley-Free classes and events - March 1-4, 2007. Elephant Pharmacy. Available at: www.elephantpharmacy.com/calendar/archive/mar2007 berkeley 01to14.pdf. Accessed March 13, 2007.
126. Anon, Final Program. American Pharmaceutical Association 142nd Annual Meeting&Exposition. American Pharmaceutical Association. Washington DC; 1995: 53.
127. L.M. Posey, Dietary supplements have not changed profession’s code of ethics, Am J Pharm Educ 71(3) (2007), 1.
128. C. Ukens, APhA considers name change, debates homeopathy. Drug Topics. Available at: www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=116590. Accessed March 13, 2007.
129. W.S. Pray, Ethical, scientific, and educational concerns with unproven medications, Am J Pharm Educ 70(6) (2006), 1-14.
130. Anon, NCPA’s mission. NCPA. Available at: www.ncpanet.org/aboutncpa/mission.php. Accessed September 16, 2008.
131. Anon, Snake oil story, NARD Journal 115(7) (1993), 12.
132. Anon, New product bulletin, Alpha CF (Advertisement), NARD Journal 111(9) (1989), 12.
133. A home study course - homeopathic pharmacy, NARD Journal 119(7) (1995), 61.
134. Anon, Rx Expo '97. NCPA Newsletter 119(4) (1997), 2.
135. Anon, Look to service-based practices, Watts advises. NCPA. Available at: www.ncpanet.org/members/pdf/ipc 0204.pdf. Accessed September 29, 2008.
136. Anon, Complementary and alternative medicine (CAM) program. Advance registration form. NCPA. 2004.
137. Anon, NCPA to launch complementary and alternative medicine portal on pharmacist E-Link. NCPA.Available at: www.ncpanet.org/media/releases/2004/ncpa to launch complementary and alternative 10-12-2004.php. Accessed September 29, 2008.
138. Anon, Homeopathy. NCPA. Available at: www.ncpanet.org/about/ncpa position statements/h.shtml#3. Accessed October 4, 2005.
139. Anon, Building a complementary and alternative medicine niche. NCPA. Available at: www.ncpanet.org/store/product info.php/products id/163. Accessed October 4, 2005.
140. J. McDermott, A. Miller, D. Weiss and T. Welder, Building a complementary and alternative medicine niche: A focus on herbal and nutritional supplements. NCPA. Available at: www.cecity.com/ncpa/nipco/cam/disclaim.htm. Accessed October 4, 2005.
141. Anon, NCPA’s 107th annual convention & trade exposition. Convention brochure. 2005.
142. J. McDermott and C. McQueen, Ten terrific ways to help your patients naturally. NCPA. Available at: www.ncpanet.org/education/edhighlights.php, Accessed September 29, 2008.
143. G. Trahan, Use your front end to drive customers into your store. NCPA. Available at: www.ncpanet.org / pdf / 2006fl frontend. pdf. Accessed September 29, 2008.
144. Anon, NCPA 2006 exhibitors. NCPA. Available at: www.ncpanet.org / pdf / 2006conv exhibitors.pdf. Accessed September 29, 2008.
145. G. Trahan, Grading your store: The store report card. NCPA. Available at: www.ncpanet.org/education/edhighlights2006.php. Accessed September 29, 2008.
146. Anon, NCPA 2007 exhibitors. NCPA. Available at: www.ncpanet.org / pdf / conv / 2007conv exhibitors.pdf. Accessed September 29, 2008.
147. Anon, NCPA 2008 exhibitors. NCPA. Available at: www.ncpanet.org / pdf / conv / 2008conv exhibitors.pdf. Accessed September 29, 2008.
148. th annual convention and trade exposition. Convention brochure. 2008.
149. J.H. Young, The Medical Messiahs, Princeton University Press. Princeton, NJ, 1967.
150. Anon, About CHPA. Consumer Healthcare Products Association. Available at: www.chpa-info.org/top.asp. Accessed June 4, 2001.
151. Anon, History. Consumer Healthcare Products Association. Available at: www.chpa-info.org/aboutchpa/History.asp. Accessed June 4, 2001.
152. NDMA Board votes name change. NDMA Special Report: January 29, 1999.
153. S. Levy, It’s now official: NDMA is CHPA, Drug Topics 143(7) (1999), 43.
154. NDMA gets a consumer-friendly name, US Pharm 24(3) 1999, 55.
155. Consumer Healthcare Products Association, Weekly Pharmacy Reports 48(5) (1999), 1.
156. M. Slezak, Practicing on pins and needles, Am Drugg 213(11) (1996), 26;28-30.
157. M. Slezak, Rite Aid advertises its vitamin expertise, Am Drugg 214(11) (1997), 13.
158. F. Batz, Integrating herbal therapy into practice, Am Drugg 215(5) (1998), 5858-5865.
159. V.E. Tyler, Why many ‘health foods’ are not safe and effective, Pharm Times 49(3) (1983), 35-37.
160. C. Grauds and J. Cox, Introduction to Aromatherapy, Pharm Times 65(9) (1999), 80.
161. C. Grauds, Selenium reduces incidence of prostate cancer, Pharm Times 65(7) (1999), 83.
162. C. Grauds, Milk thistle: A potential life-saver, Pharm Times 62(3) (1996), 95.
163. C. Grauds, Treating migraine and arthritis with feverfew, Pharm Times 61(7) (1995), 32;34.
164. M. Sherman, Natural medicines: A rare opportunity for pharmacists, Pharm Times 63(11) (1997), 80;82.
165. E. McCormick, Modern and traditional medicines: Can they coexist? Pharm Times 64(10) (1998), 71-72.
166. RONH10@JUNO.com. Concern over herbals (Letter), Pharm Times 63(12) (1997), 8.
167. D.J. Pacy, "Unleashed herbal explosion" (Letter), Pharm Times 65(8) (1999), 12.
168. Y.C. Terrie, Antisnoring products, Pharm Times 71(8) (2005), 11;15-16.
169. Anon, OTC product news. Alphactif for Men, Pharm Times 71(8) (2005), 18.
170. A.D. Garrett, Complementary medicine and diabetes: What’s fact, what’s fiction? Pharm Times 71(8) (2005), 34.
171. Anon, Appearex (Advertisement). Pharm Times 71(8) (2005), 35.
172. W.S. Pray, Quackery, a deadly threat to health, US Pharm 16(5) (1991), 35-36;39-40.
173. C. Kwong-Robbins, Traditional Chinese medicine - a natural and holistic approach, US Pharm 27(12) (2002), 44;46;48-50.
174. C. Kwong-Robbins, The art and science of Chinese herbal medicine, US Pharm 28(3) (2003), 62;65;68;71;75.
175. Anon, Drug Store News, Drug Store News. Available at: www.drugstorenews.com/. Accessed January 6, 2006.
176. J.B. Lavalle, Treating women’s health the natural way, Drug Store News 8 (1998), CP31.
177. R. Eder, OTC giants join herbal game, Drug Store News 7 (1997), 27.
178. Anon, Nature’s Essence Blood Tonic Syrup (Advertisement), Drug Store News 8 (1998), CP14.
179. K. Snyder, R. Ph.s can learn more about CAM, Drug Topics 140(22) (1996), 52.
180. J. Bennett, The best pharmacy practices: Innovative or diverse services, Drug Topics 141(8) (1997), 96-105.
181. K. Snyder, Cold-Eeze lozenges are taking the nation by storm, Drug Topics 141(3) (1997), 16;19.
182. W.M. Davis, The role of glucosamine and chondroitin sulfate in the management of arthritis, Drug Topics (supplement), 142(8) (1998), 1S-15S.
183. E. Portyansky, Alternative medicine-how bountiful is the harvest? Drug Topics 142(7) (1998), 44-45;47;49-50.
184. G.M. Tarlach, Turning herbs ‘N2' profits, Drug Topics 142(2) (1998), 66.
185. S. Levy, M.D.s issue call for testing alternative medications, Drug Topics 142(19) (1998), 21.
186. H. Fleming, Jr., A natural progression, Drug Topics 142(18) (1998), 74.
187. Levy S. Reading, writing … and complementary care, Drug Topics 143(21) (1999), 42;44.
188. S. Levy, Don’t miss this boat, Drug Topics 143(5) (1999), 41-42;44;49.
189. S. Levy, R. Ph. finds consumers becoming complementary care friendly, Drug Topics 143(20) (1999), 61.
190. H. Fleming, Jr., Two in one, Drug Topics 143(2) (1999), 15.
191. J.S.Williamson and C.M.Wyandt, New perspectives on alternative medicine, Drug Topics 145(1) (2001), 57-66.
192. A.M. Kratz, Flawed article (Letter), Drug Topics 145(5) (2001), 18.
193. Anon, Allen Kratz, Premiere Speakers Bureau. Available at: http://premierespeakers.com/1066/index.cfm. Accessed January 9, 2006.
194. Kwong-Robbins C. Setting record straight on herbs (Letter), Drug Topics 145(13) (2001), 12;15.
195. J.H. McDermott, J.E. Riedlinger and E. Chapman, What pharmacists should understand about homeopathic remedies, Am J Health-Syst Pharm 52(21) (1995), 2442-2445.
196. D.M. Rowell and D.J. Kroll, Complementary and alternative medicine education in United States pharmacy schools, Am J Pharm Educ 62 (1998), 412-419.